FIELD: chemistry.
SUBSTANCE: present invention pertains to new compounds with general formula I, where R1 represents -(CHR')q-aryl or -(CHR')q-thiophen, which are unsubstituted or mono-, di- or tri-substituted with (inferior)alkyl, (inferior)alkoxy, CF3 or haloid, or represents (inferior)alkyl, (inferior)alkenyl, -(CH2)n-Si(CH3)3, -(CH2)n-O-(inferior)alkyl, -(CH2)n-S- (inferior)alkyl, -(CH2)q-cycloalkyl, -(CH2)n-[CH(OH)]m-(CF2)p-CHqF(3-q), or represents -(CH2)n-CR2-CF3, where two radicals R together with a carbon atom form a cycloalkyl ring; R' represents hydrogen or (inferior)alkyl; n is 1, 2 or 3; m is 0 or 1; p is 0, 1,2, 3, 4, 5 or 6; q is 0, 1, 2 or 3; R2 represents hydrogen or (inferior)alkyl; R3 represents hydrogen, (inferior)alkyl, CH2F, aryl, optionally mono-, di- or tri-substituted with a haloid, or represents -(CH2)nNR5R6, where R5 and R6 independently represent hydrogen or (inferior)alkyl; R4 represents one of the following groups a) or b), where R7 represents inferior)alkyl or -(CH2)ncycloalkyl; R8 and R9 independently represent hydrogen, (inferior)alkyl, -(CH2)n-cycloalkyl or -C(O)-phenyl. The invention also relates to pharmaceutically used acid addition salts of these compounds, optically pure enantiomers, racemates or diastereomeric mixtures, as well as compounds with general formula I-1, and medicinal agent.
EFFECT: obtaining new biologically active compounds, designed for inhibiting γ-secretase.
16 cl, 83 ex
Title | Year | Author | Number |
---|---|---|---|
MALONAMIDE DERIVATIVES AS γ-SECRETASE INHIBITORS | 2007 |
|
RU2440342C2 |
METHODS FOR THE TREATMENT OF COCHLEAR SYNAPTOPATHY | 2017 |
|
RU2757276C2 |
MALONAMIDE DERIVATIVES AS γ-SECRETASE INHIBITORS | 2004 |
|
RU2330849C2 |
HETEROCYCLIC CONDENSED COMPOUNDS USEFUL AS ANTIDIURETIC AGENTS | 2005 |
|
RU2359969C2 |
COMBINATION THERAPY AND METHOD FOR ASSESSING RESISTANCE TO TREATMENT | 2011 |
|
RU2587053C2 |
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND THEIR ESTERS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITION OF NEUROGENOUS PAIN, INFLAMMATION AND BLOOD GLUCOSE LEVEL IN PATIENT | 1996 |
|
RU2244713C2 |
HETEROCYCLIC NITROGEN PYRROLE DERIVATIVES, PRODUCING THEM AND PHARMACEUTICAL APPLICATION | 2008 |
|
RU2473543C2 |
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2404163C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
NON-STEROIDAL MODULATORS OF PROGESTERONE RECEPTOR | 2003 |
|
RU2309155C2 |
Authors
Dates
2009-05-27—Published
2004-09-27—Filed